The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Samoĭlova Iu.G.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Novoselova M.V.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Kostiunina A.K.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Pirmagomedova É.D.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Latypov A.V.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Predictors of the development of encephalopathy in the patients presenting with diabetes mellitus

Authors:

Samoĭlova Iu.G., Novoselova M.V., Kostiunina A.K., Pirmagomedova É.D., Latypov A.V.

More about the authors

Journal: Problems of Endocrinology. 2013;59(5): 67‑71

Read: 707 times

Download PDF (RU)
Contact the author
Table of contents

PREDICTORS OF THE DEVELOPMENT OF ENCEPHALOPATHY IN THE PATIENTS PRESENTING WITH DIABETES MELLITUS
PREDICTORS OF THE DEVELOPMENT OF ENCEPHALOPATHY IN THE PATIENTS PRESENTING WITH DIABETES MELLITUS

To cite this article:

Samoĭlova IuG, Novoselova MV, Kostiunina AK, Pirmagomedova ÉD, Latypov AV. Predictors of the development of encephalopathy in the patients presenting with diabetes mellitus. Problems of Endocrinology. 2013;59(5):67‑71. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Effi­ciency of complex medi­cal reha­bilitation after pulmonary enda­rterectomy. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):629-636
Simu­ltaneous auto­plastic repair and diastasis recti correction for linea alba hernias. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):34-39
Predictors of Enga­gement and Active participation of Patients with Unco­ntrolled Hype­rtension in the Tele­health Surveillance Program. Russian Journal of Preventive Medi­cine. 2024;(12):37-43
Effe­ctiveness of the second stage program of medi­cal reha­bilitation of patients with ischemic heart disease. Russian Journal of Preventive Medi­cine. 2024;(12):75-80
Asse­ssment of risk of deve­loping fractures and sarcopenia and quality of life of patients with chro­nic kidney disease at the outpatient stage. Russian Journal of Preventive Medi­cine. 2024;(12):88-91
Reco­mmendations for the reha­bilitation of patients with chro­nic kidney disease requiring hemo­dialysis (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):62-73
The Effect of Standardized Doses of Hesperidin and Diosmin on Venous Wall Remo­deling in Patients with Primary Vari­cose Veins: a Prospective Controlled Study “STANDARD”. Journal of Venous Diso­rders. 2024;(4):293-301
Effect of Sulo­dexide on Endo­thelial Function and Quality of Life in Patients with Vari­cose Veins. Journal of Venous Diso­rders. 2024;(4):308-316
Asse­ssment of visual functions within the sensory domain of intrinsic capa­city in older adults. Russian Annals of Ophthalmology. 2024;(6):45-54
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Abstract:

The present review encompasses the data from the Russian-language and foreign publications. Diabetes mellitus (DM) is currently considered to be a global socio-medical, psychological, and economic problem due to the high frequency of vascular complications resulting in early invalidization of the patients. Encephalopathy (EP) is one of the most severe complications of DM leading to the substantial deterioration of the quality of life. Both the markers and the diagnostic criteria of EP remain to be determined. Certain neurospecific proteins are believed to be predictors of this pathology.

Keywords:

type 1 diabetes mellitus
encephalopathy
quality of life
neurospecific proteins

Authors:

Samoĭlova Iu.G.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Novoselova M.V.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Kostiunina A.K.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Pirmagomedova É.D.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Latypov A.V.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Close metadata

References:

  1. Suntsov Yu.I., Bolotskaya L.L., Maslova O.V., Kazakov I.V. Epidemiologiya sakharnogo diabeta i prognoz ego rasprostranennosti v Rossiiskoi Federatsii. Sakharnyi diabet 2011; 1: 15-18.
  2. Shiryaeva T.Yu., Andrianova E.A., Suntsov Yu.I. Dinamika zabolevaemosti i rasprostranennosti sakharnogo diabeta 1-go tipa u detei v Rossiiskoi Federatsii v 2001-2007 gg. Sakharnyi diabet 2006; 3: 6-11.
  3. Balabolkin M.I. Diabetologiya. M: Meditsina 2000.
  4. Samoilova Yu.G., Semke V.Ya., Belokrylova M.F., Oleinik O.A., Enert A.V. Vliyanie psikhologicheskikh faktorov na dostizhenie kompensatsii sakharnogo diabeta 1-go tipa v detskom i podrostkovom vozrastakh. Sib vestn psikhiat i narkol 2010; 1: 35-40.
  5. Chugunova L.A., Semenova I.V., Shestakova M.V. Rannyaya diagnostika khronicheskoi ishemii mozga s primeneniem sovremennykh immunovospalitel'nykh markerov i instrumental'nykh metodov u bol'nykh s cakharnym diabetom: posobie dlya vrachei. M 2007.
  6. Starostina E.G. Biomeditsinskie i psikhosotsial'nye aspekty sakharnogo diabeta i ozhireniya: vzaimodeistvie vracha i patsienta i puti ego optimizatsii: Avtoref. dis. ... d-ra med. nauk. M 2003.
  7. Jacobsonde A.M., Groot M., Samson J.A. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17: Issue 4: 267-274.
  8. Samoilova Yu.G., Oleinik O.A. Integral'nye pokazateli kachestva zhizni detei i podrostkov s sakharnym diabetom 1-go tipa. Pediatriya 2010; 89: 5: 57-63.
  9. Shishkina T.M. Autoantitela k osnovnomu belku mielinu u detei s diabeticheskoi neiropatiei. Sib med zhurn 2005; 50-52.
  10. Brands I. Diabetes and the brain: Cognitive performance in type 1 and type 2 diabetes mellitus. New York: Gildeprint Drukkerijen B.V. 2007.
  11. Markin S.P. Proyavleniya sakharnogo diabeta. Consilium Medicum (Nevrologiya/revmatologiya) 2011; 1: 60-63 (prilozhenie).
  12. Trudeau F., Gagnon C., Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 2004; 490: 177-186.
  13. Lechuga-Sancho A.M., Arroba A.I., Frago L.M., García-Cáceres C., de Célix A.D., Argente J., Chowen J.A. Reduction in the number of astrocytes and their projections is associated with increased synaptic protein density in the hypothalamus of poorly controlled diabetic rats. Endocrinology 2006; 147: 11: 5314-5324.
  14. Palo J., Reske-Nielsen E., Riekkinen P. Enzyme and protein studies of demyelination in diabetes. J Neurol Sci 1977; 33: 1-2: 171-178.
  15. Senatorova A.S., Karpchentsev Yu.I., Kravchun N.A., Kazakov A.V, Riga E.A., Makeeva N.I., Chaichenko T.V. Sakharnyi diabet: ot rebenka do vzroslogo: monografiya. Khar'kov: KhNMU 2009.
  16. Chuiko M.R., Bodykhov M.K., Skvortsova V.I. Kharakteristika i osobennosti techeniya entsefalopatii pri insulinzavisimom sakharnom diabete. Zhurn nevrol i psikhiatr 2010; 5: 4-8.
  17. Biessels G.J., Luchsinger J.A. Pathobiology of Diabetic Encephalopathy in Animal Models. Diabetes and the Brain Contemporary Diabetes. New York: Springer LLC, 2010; 409-431.
  18. Grishanova T.G., Budaev A.V., Grigor'ev E.V. Povrezhdenie golovnogo mozga pri tyazheloi travme: znachimost' klinicheskikh shkal i neironal'nykh marekrov. Meditsina neotlozhnykh sostoyanii 2011; 32-33.
  19. Nechunaeva E.V. Immuno-biokhimicheskie pokazateli v rannei diagnostike khronicheskoi ishemii golovnogo mozga: Avtoref. dis. ... kand. med. nauk. Ekaterinburg 2010.
  20. Zimmer D.B., Weber D.J. The Calcium-Dependent Interaction of S100B with Its Protein Targets. Cardiovasc Psychiat Neurol 2010; 2010: 1-18.
  21. Belok S100 URL. http://humbio.ru/humbio/ishemia/000d3ac2.htm (data obrashcheniya 06.01.2013)
  22. Gruden' M.A., Storozheva Z.I., Sherstnev V.V. Regulyatornye antitela k neirotroficheskim faktoram: kliniko-eksperimental'noe issledovanie. V kn.: Neiroimmunopatologiya. M 1999; 19-20.
  23. Scotto C., Deloulme J.C., Rousseau D., Chambaz E., Baudier J. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol Cell Biol 1998; 18: Issue 7: 4272-4281.
  24. Friend W.C., Clapoff S., Landry C., Becker L.E., O'Hanlon D., Allore R.J., Brown I.R., Marks A., Roder J., Dunn R.J. Cell-specific expression of high levels in human S100Β intransgenic mouse brain is dependent of gene dosage. J Neurosci 1992; 12: 4337-4346.
  25. Gerlai R., Wojtowicz J.M., Marks A., Roder J. Over expression of a calcium-binding protein, S100L, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice. Learn Mem 1995; 2: 26-39.
  26. Whitaker-Azmitia P.M., Wingate M., Borella A., Gerlai R., Roder J., Azmitia E. Transgenic mice overexpressing the neurotrophic factor S-100Β show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res 1997; 776: 378-381.
  27. Winocur G., Roder J., Lobaugh N. Learning and memory in S100-Β transgenic mice: an analysis of impaired and preserved function. Neurobiol Learn Mem 2001; 75: 230-243.
  28. Grabe H.J., Ahrens N., Rose H.J., Kessler C., Freyberger H.J. Neurotrophic factor S100beta in major depression. Neuropsychobiology 2001; 44: 88-90.
  29. Rothermundt M., Arolt V., Wiesmann M., Missler U., Peters M., Rudolf S., Kirchner H. S-100B is increased in melancholic but not in non-melancholic major depression. J Affect Dis 2001; 66: 89-93.
  30. McIntyre E.A., Perros P. Serum S-100beta protein as a biochemical marker for cerebral oedema complicating severe diabetic ketoacidosis. Diabet Med 2001; 18: 12: 1008R.
  31. Roder G.J. Abnormal exploratory behavior in transgenic mice carrying multiple copies of the human gene for S100Β. J Psychiatr Neurosci 1995; 20: 105-112.
  32. Puzikova O.Z. Kliniko-patogeneticheskie aspekty formirovaniya tserebral'nykh narushenii pri sakharnom diabete 1-go tipa u detei i podrostkov. Mezhdunar endokrinol zhurn 2010; 8: 32.
  33. Strachan M.W., Abraha H.D., Sherwood R.A., Lammie G.A., Deary I.J., Ewing F.M., Perros P., Frier B.M. Evaluation of serum markers of neuronal damage following severe hypoglycaemia in adults with insulin-treated diabetes mellitus. Diabet Metabol Res Rev 1999; 15: 1: 5-12.
  34. Hovsepyan M.R., Haas M.J., Boyajyan A.S., Guevorkyan A.A., Mamikonyan A.A., Myers S.E., Mooradian A.D. Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus. Neurosci Lett 2004; 21: 369: 3: 224-227.
  35. Samoilova Yu.G., Semke V.Ya., Belokrylova M.F., Oleinik O.A., Enert A.V. Vliyanie psikhologicheskikh faktorov na dostizhenie kompensatsii sakharnogo diabeta 1-go tipa v detskom i podrostkovom vozrastakh. Sib vestn psikhiatr i narkol 2010; 1: 35-40.
  36. Pavlov K.A. Poluchenie i immunokhimicheskii analiz rekombinantnogo gliofibrillyarnogo kislogo proteina: Avtoref. dis. ... kand. biol. nauk. M 2009.
  37. Blennow M., Hagberg H., Rosengren L. Glial fibrillary acidic protein in the cerebrospinal fluid: a possible indicator of prognosis in full-term asphyxiated newborn infants? Pediatr Res 1995; 37: 260-264.
  38. Chekhonin V.P., Gurina O.I., Dmitrieva T.E., Shepeleva I.I., Babich G.N. Monoklonal'nye anti-GFAP antitela: poluchenie kharakteristika i immunofermentnyi analiz. BEBM 2001; 8: 188-191.
  39. Petzold A., Keir G., Green A.J.E., Giovannoni G., Thompson E.J. An ELISA for glial fibrillary acidic protein. J IMMunol Methods 2004; 287: 169-177.
  40. Coleman E., Judd R., Hoe L., Dennis J., Posner P. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 2004; 48: 2: 166-178.
  41. Li Jing, Qingping He, Jian-Zhong Zhang, Andy Li P. Temporal Profile of Astrocytes and Changes of Oligodendrocyte-Based Myelin Following Middle Cerebral Artery Occlusion in Diabetic and Non-diabetic Rats. Int J Biol Sci 2013; 9: 2: 190-199.
  42. Yang J., DeVisser A., Martinez J.A., Poliakov I., Rosales-Hernandez A., Ayer A., Garven A., Zaver S., Rincon N., Xu K., Tuor U.I., Schmidt A.M., Toth C. Differential impact of diabetes and hypertension in the brain: adverse effects in white matter. Neurobiol Dis 2011; 42: 3: 446-458.
  43. Lechuga-Sancho A.M., Arroba A.I., Frago L.M., Pañeda C., García-Cáceres C., Delgado Rubín de Célix A., Argente J., Chowen J.A. Activation of the intrinsic cell death pathway, increased apoptosis and modulation of astrocytes in the cerebellum of diabetic rats. J Neurocytol 2005; 34: 1-2: 3-10.
  44. Afsari Z.H., Renno W.M., Abd-El-Basset E. Alteration of glial fibrillary acidic proteins immunoreactivity in astrocytes of the spinal cord diabetic rats. Anat Rec (Hoboken). 2008; 291: 4: 390-399.
  45. Chekhonin V.P., Gurina O.I., Dmitrieva T.B., Semenova A.V., Savchenko E.A., Grigor'ev M.E. Osnovnoi belok mielina, stroenie, svoistva, funktsii, rol' v diagnostike demieliniziruyushchikh zabolevanii. Biomed khimiya 2000; 6: 549-563.
  46. Lara S., Foland-Ross C., Thompson P.M., Sugar C.A., Madsen S.K., Shen J.K., Penfold C., Ahlf B.K., Rasser P.E., Fischer J., Yang Y., Townsend J., Bookheimer S.Y., Altshuler L.L. Investigation of Cortical Thickness Abnormalities in Lithium-Free Adults With Bipolar I Disorder Using Cortical Pattern Matching. J Psychiat 2011; 168: 530-539.
  47. Pesaresi M., Giatti S., Calabrese D., Maschi O., Caruso D., Melcangi R.C. Dihydroprogesterone increases the gene expression of myelin basic protein in spinal cord of diabetic rats. J Mol Neurosci 2010; 42: 2: 135-139.
  48. Shishkova Yu.A., Motovilin O.G., Divisenko S.I., Surkova E.V., Maiorov A.Yu. Kachestvo zhizni bol'nykh sakharnym diabetom 1-go tipa molodogo vozrasta. Sakharnyi diabet 2010; 4: 43-47.
  49. Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. 2-e izd. Pod red. I.I. Dedova, M.I. Shestakovoi. M 2009.
  50. Alimova I.L., Kozlova L.V., Sukhorukov V.S. Serdechno-sosudistye oslozhneniya pri sakharnom diabete 1-go tipa u detei i ikh korrektsiya. Ros vestn perinatol i pediatr 2004; 49: 4: 24-29.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.